Detection of BRAF splicing variants in plasma-derived cell-free nucleic acids and extracellular vesicles of melanoma patients failing targeted therapy therapies

The analysis of plasma circulating tumour nucleic acids provides a non-invasive approach to assess disease burden and the genetic evolution of tumours in response to therapy. BRAF splicing variants are known to confer melanoma resistance to BRAF inhibitors. We developed a test to screen cell-free RN...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Clark, Michael E., Rizos, Helen, Pereira, Michelle R., McEvoy, Ashleigh C., Marsavela, Gabriela, Calapre, Leslie, Meehan, Katie, Ruhen, Olivia, Khattak, Muhammad A., Meniawy, Tarek M., Long, Georgina V., Carlino, Matteo S., Menzies, Alexander M., Millward, Michael, Ziman, Melanie, Gray, Elin S.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7646833/
https://ncbi.nlm.nih.gov/pubmed/33216826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27790
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars